VIVOLTA
Assembly Line
VIVOLTA Raises €7 Million Financing to Further Execute Its Growth Strategy as Medical Electrospinning CDMO
VIVOLTA, a world leader in the development and manufacturing of electrospun medical products, announced that it has raised €7M in a new funding round with participation from existing shareholders and the Dutch government’s NXTGEN HIGHTECH growth fund.
These funds will enable us to further advance our initiatives to transform our partners’ design concepts into fully scalable commercial products. Moreover, our MediSpinTM platform gives us a strong advantage by being able to commercially manufacture electrospun medical products with the quality, consistency, and volumes required by the medical industry.